| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
12 Aberrant beta-catenin distribution as potential prognosticator for endometrioid endometrial cancer recurrence
|
Moon, Ashley S.
|
|
|
48 |
S1 |
p. S7
|
artikel
|
| 2 |
5 Acceptability of HPV self-collection and the role of telehealth: a prospective, randomized study stratified by menopausal status
|
Fitch, Katherine C.
|
|
|
48 |
S1 |
p. S3
|
artikel
|
| 3 |
20 An assessment of changes in measures of quality of life and financial well-being over time among ovarian cancer patients
|
Adjei, Naomi N.
|
|
|
48 |
S1 |
p. S11-S12
|
artikel
|
| 4 |
48 An evidence-based approach to prescribing post-discharge opioids after laparotomy
|
Kay, Allison H.
|
|
|
48 |
S1 |
p. S25
|
artikel
|
| 5 |
57 A roadmap to safety: decreased intraoperative injury with a multidisciplinary approach to placenta accreta
|
Levy, Rachel
|
|
|
48 |
S1 |
p. S29-S30
|
artikel
|
| 6 |
28 Assessment of malignancy type-specific COVID-19 case-fatality in the United States
|
Vallejo, Andrew
|
|
|
48 |
S1 |
p. S16
|
artikel
|
| 7 |
27 Association of anal dysplasia with cervical dysplasia and high-risk HPV subtypes in women
|
Chaudhari, Sonal
|
|
|
48 |
S1 |
p. S14-S15
|
artikel
|
| 8 |
30 Attenuation of COVID-19 infection among patients with endometrial and cervical cancer receiving immunotherapy
|
Shammas, Natalie L.
|
|
|
48 |
S1 |
p. S17
|
artikel
|
| 9 |
AUTHOR INDEX
|
|
|
|
48 |
S1 |
p. S38-S39
|
artikel
|
| 10 |
46 Beyond rounds: improving physician wellness on the gynoncology service through meaningful connection
|
Rubin, Nicole
|
|
|
48 |
S1 |
p. S24
|
artikel
|
| 11 |
34 Cancer survival in women diagnosed with leiomyosarcoma of the uterus
|
Curtin, Christina
|
|
|
48 |
S1 |
p. S19
|
artikel
|
| 12 |
36 Characteristics and management of malignant mesonephric tumors of the female genital tract: a surveillance, epidemiology, and end results database study
|
Greenberg, Danielle
|
|
|
48 |
S1 |
p. S19-S20
|
artikel
|
| 13 |
65 Characterization of genomic and social determinants of health in the TP53 mutational landscape of non-cancerous endometrium during the lifespan of Black and White individuals
|
Rios-Doria, Eric
|
|
|
48 |
S1 |
p. S33-S34
|
artikel
|
| 14 |
63 Chemical inhibition of SWI/SNF induces transformed growth in non-mutant cells, mimicking the effects of a SMARCA4 mutation associated with small cell carcinoma of the ovary, hypercalcemic type
|
Krieg, Adam J.
|
|
|
48 |
S1 |
p. S32-S33
|
artikel
|
| 15 |
56 Clinical and pathological factors that predict survival in patients undergoing pelvic exenterations for gynecological malignancies
|
Fadadu, Priyal P.
|
|
|
48 |
S1 |
p. S28-S29
|
artikel
|
| 16 |
40 Comparison of contemporary management and outcomes of patients with transitional cell carcinomas and malignant Brenner tumors of the ovary
|
Coakley, Katherine
|
|
|
48 |
S1 |
p. S22
|
artikel
|
| 17 |
24 Correlation of clinical outcomes and poly ADP ribose polymerase activity in high grade serous ovarian cancer
|
Fleming, Elaine T.
|
|
|
48 |
S1 |
p. S13
|
artikel
|
| 18 |
41 COVID-19 vaccination in cancer patients receiving chemotherapy: does vaccination increase the risk of hypersensitivity reactions?
|
Treiman, Sierra M.
|
|
|
48 |
S1 |
p. S22
|
artikel
|
| 19 |
25 Crowdfunding pages identify unmet needs among gynecologic cancer patients
|
O'Connor, Reed
|
|
|
48 |
S1 |
p. S14
|
artikel
|
| 20 |
52 Decision-making regarding ovarian cancer risk-reduction among women of color who carry a BRCA mutation
|
Friedman, Emmeline
|
|
|
48 |
S1 |
p. S26-S27
|
artikel
|
| 21 |
15 Development of a student-led cervical cancer patient education and navigation program
|
Louis, Gemma St.
|
|
|
48 |
S1 |
p. S9
|
artikel
|
| 22 |
69 Disparities in breast cancer screening adherence among Hispanic women who receive cervical cancer screening
|
Ge, Grace R.
|
|
|
48 |
S1 |
p. S35-S36
|
artikel
|
| 23 |
61 Do the Peters criteria hold up for adenocarcinoma? A retrospective database study evaluating the effect of histology on outcomes in surgically-treated high-risk early stage cervical cancer
|
Greenberg, Danielle
|
|
|
48 |
S1 |
p. S31-S32
|
artikel
|
| 24 |
Editorial Board
|
|
|
|
48 |
S1 |
p. i
|
artikel
|
| 25 |
64 Effect of perioperative app on use of emergency medical services for patients recovering from laparotomy
|
Marshalla, Megan
|
|
|
48 |
S1 |
p. S33
|
artikel
|
| 26 |
42 Evaluation of pseudoprogression on immune checkpoint inhibitor therapy in gynecologic cancers
|
Akapo, Adeola
|
|
|
48 |
S1 |
p. S22
|
artikel
|
| 27 |
1 Examining the immune tumor microenvironment of endometrial cancer patients treated with pembrolizumab plus lenvatinib
|
Carballo, Erica V.
|
|
|
48 |
S1 |
p. S1
|
artikel
|
| 28 |
16 Fertility outcomes in women with hereditary cancer syndromes
|
Connelly, Elizabeth
|
|
|
48 |
S1 |
p. S10
|
artikel
|
| 29 |
13 Glucocorticoids promote granulosa cell tumor growth and antagonize paclitaxel via a FOXL2 c.C402G-dependent mechanism
|
Hillman, Robert T.
|
|
|
48 |
S1 |
p. S7-S8
|
artikel
|
| 30 |
68 Gynecologic and breast cancer patient experiences with scalp cooling to reduce alopecia
|
Tewari, Sujata E.
|
|
|
48 |
S1 |
p. S35
|
artikel
|
| 31 |
17 Help wanted: identifying and addressing sexual distress in newly referred gynecologic oncology patients
|
Jang, Allyson
|
|
|
48 |
S1 |
p. S10
|
artikel
|
| 32 |
19 HIV prevalence by age at a single institution providing cervical cancer screening and treatment for women in the Southern Region of Malawi
|
Guthrie, Laurel
|
|
|
48 |
S1 |
p. S11
|
artikel
|
| 33 |
21 Hormone replacement therapy utilization over time following risk-reducing salpingo-oophorectomy in premenopausal patients at high risk for ovarian cancer
|
Ghezelayagh, Talayeh
|
|
|
48 |
S1 |
p. S12
|
artikel
|
| 34 |
6 How many lines is too many? Real world patterns of number of lines of chemotherapy in platinum resistant ovarian cancer
|
Goon, Kelsey C.
|
|
|
48 |
S1 |
p. S3-S4
|
artikel
|
| 35 |
37 HPV vaccination rates among women 27–45 rose more slowly after ACOG's statement recommending shared decision making
|
Bondre, Ioana L.
|
|
|
48 |
S1 |
p. S20
|
artikel
|
| 36 |
62 Identifying barriers to initiation of pelvic floor therapy: life after gynecologic cancer
|
Zhang, Caroline
|
|
|
48 |
S1 |
p. S32
|
artikel
|
| 37 |
55 If you don't use it, lose it: reducing over prescription of opioids at discharge
|
McGough-Maduena, Alison
|
|
|
48 |
S1 |
p. S28
|
artikel
|
| 38 |
2 Immune related adverse events in endometrial cancer: a biomarker for treatment efficacy?
|
Popat, Vinita
|
|
|
48 |
S1 |
p. S1-S2
|
artikel
|
| 39 |
67 Immunotherapy in recurrent endometrial cancer: who derives benefit?
|
Kar-Kasal, Ayesha
|
|
|
48 |
S1 |
p. S34-S35
|
artikel
|
| 40 |
18 Impact of multi-variable social vulnerability on cervical cancer prevention in Hispanic women
|
Garcia, Eduardo
|
|
|
48 |
S1 |
p. S10-S11
|
artikel
|
| 41 |
60 Intraoperative radiation therapy in the treatment of recurrent cervical and endometrial cancer: analysis of postoperative complications
|
Howlett, Lindsay N.
|
|
|
48 |
S1 |
p. S31
|
artikel
|
| 42 |
58 In vitro chemosensitivity of patient-derived ovarian cancer samples is not correlated with homologous recombination deficiency, platinum sensitivity, or cancer stem cell frequency
|
Badinef, Nora
|
|
|
48 |
S1 |
p. S30
|
artikel
|
| 43 |
45 Lenvatinib for endometrial cancer: reducing healthcare disparities and emphasizing equitable medication access through quality improvement
|
Holloway, Steven Blaine
|
|
|
48 |
S1 |
p. S23-S24
|
artikel
|
| 44 |
29 Low-grade endometrioid endometrial cancer with adnexal metastasis: possible de-escalation candidate for adjuvant therapy?
|
Vallejo, Andrew
|
|
|
48 |
S1 |
p. S16-S17
|
artikel
|
| 45 |
47 Non-English language as a barrier to postoperative pain management
|
Levy, Rachel
|
|
|
48 |
S1 |
p. S24
|
artikel
|
| 46 |
71 No survival difference in patients receiving radical hysterectomy vs. extrafascial hysterectomy in stage II–IV endometrial cancer patients: a multivariate analysis
|
Palkowski, Teresa
|
|
|
48 |
S1 |
p. S36
|
artikel
|
| 47 |
35 Obese microenvironmental signaling and junctional protein disruption in endometrial cells: an early pro-oncogenic change?
|
Ross, Megan E.
|
|
|
48 |
S1 |
p. S19
|
artikel
|
| 48 |
66 Overexpression of the microRNA let-7i does not consistently enhance sensitivity to cisplatin in vitro in patient-derived epithelial ovarian carcinoma samples
|
Badiner, Nora
|
|
|
48 |
S1 |
p. S34
|
artikel
|
| 49 |
49 Panniculectomy to facilitate minimally invasive hysterectomy is effective for severely obese patients undergoing gynecological oncological surgery
|
Manek, Roxanne AR.
|
|
|
48 |
S1 |
p. S25
|
artikel
|
| 50 |
7 Patients with disease recurrence report more unmet social needs: an evaluation across the gynecologic cancer continuum
|
Cotangco, Katherine
|
|
|
48 |
S1 |
p. S4-S5
|
artikel
|
| 51 |
22 Patients with stage 1 endometrial cancer frequently do not receive guideline recommended postoperative radiation
|
Nguyen, Christine G.T.
|
|
|
48 |
S1 |
p. S12-S13
|
artikel
|
| 52 |
26 Patterns of palliative care referral and inpatient to outpatient palliative care transition in gynecological cancer patients with a focus on primary language: a single institution retrospective study
|
Huang, Dandi
|
|
|
48 |
S1 |
p. S14
|
artikel
|
| 53 |
8 Pembrolizumab (P) +/– lenvatinib (L) in patients with advanced endometrial cancer (EC) in northern California
|
Seto, Tiffany
|
|
|
48 |
S1 |
p. S5
|
artikel
|
| 54 |
53 Planned interim analysis of a randomized trial comparing epidural to surgical site infiltration with liposomal bupivacaine for gynecologic oncology patients undergoing laparotomy
|
Hazimeh, Dana
|
|
|
48 |
S1 |
p. S27
|
artikel
|
| 55 |
11 Planned robotic-assisted interval hysterectomy for the management of placenta accreta spectrum
|
Antonioli, Samantha H.
|
|
|
48 |
S1 |
p. S6-S7
|
artikel
|
| 56 |
54 Poor self-rated mental health affected cervical cancer screening rates during the COVID-19 pandemic
|
Haney, Karen E.
|
|
|
48 |
S1 |
p. S27-S28
|
artikel
|
| 57 |
23 Post-operative care for patients undergoing hyperthermic intraperitoneal chemotherapy (HIPEC): is there room to de-escalate post-operative care?
|
Persenaire, Christianne
|
|
|
48 |
S1 |
p. S13
|
artikel
|
| 58 |
59 Prognosis of cervical cancer when diagnosed during pregnancy
|
Makepeace, Lydia M.
|
|
|
48 |
S1 |
p. S30-S31
|
artikel
|
| 59 |
14 Prognostic role of the molecular classification in endometrial cancer patients with cervical stromal invasion
|
Reyes-Baez, Fiorella E.
|
|
|
48 |
S1 |
p. S8-S9
|
artikel
|
| 60 |
51 Relative incidence of uterine cancer in Black patients compared to White patients in the US
|
Wong, Deanna H.
|
|
|
48 |
S1 |
p. S26
|
artikel
|
| 61 |
43 Severe maternal morbidity is increased among pregnant persons with gynecological malignancies
|
Fitch, Katherine C.
|
|
|
48 |
S1 |
p. S23
|
artikel
|
| 62 |
3 Shifting trends in diagnosis of high-grade serous tubo-ovarian carcinoma: a population-based assessment
|
Lee, Matthew
|
|
|
48 |
S1 |
p. S2
|
artikel
|
| 63 |
39 Somatic NF1 alterations as potential biomarker for response to immune checkpoint inhibition in recurrent ovarian cancer
|
Moon, Ashley S.
|
|
|
48 |
S1 |
p. S21
|
artikel
|
| 64 |
70 Surgical outcomes for robotic-assisted single-site hysterectomy as compared to multi-site hysterectomy: a single institution retrospective study
|
Reddy, Ravali A.
|
|
|
48 |
S1 |
p. S36
|
artikel
|
| 65 |
44 The clot thickens: identifying risk factors for VTE in metastatic and recurrent cervical cancer
|
Edwards, Carson C.
|
|
|
48 |
S1 |
p. S23
|
artikel
|
| 66 |
33 The impact of social media on anxiety and depression among patients with neuroendocrine carcinoma of the cervix: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study
|
Saab, Reem
|
|
|
48 |
S1 |
p. S18-S19
|
artikel
|
| 67 |
50 Therapeutic opportunities in the master transcription factor circuitries of clear cell carcinomas
|
Kinne, Nolan J.
|
|
|
48 |
S1 |
p. S25-S26
|
artikel
|
| 68 |
4 Therapeutic utility of EC359 for targeting LIFR signaling in Type II endometrial cancer
|
Spencer, Nicole M.
|
|
|
48 |
S1 |
p. S2
|
artikel
|
| 69 |
31 Trends in estimated percent of patients with epithelial ovarian cancer eligible for and responding to PARP inhibitors over time
|
Carballo, Erica V.
|
|
|
48 |
S1 |
p. S17-S18
|
artikel
|
| 70 |
32 Trends in ovarian cancer incidence and incidence-based mortality: a 15-year population-based analysis
|
Somasegar, Sahana
|
|
|
48 |
S1 |
p. S18
|
artikel
|
| 71 |
72 Two-year follow up on the impact of the COVID-19 pandemic on outcomes in gynecologic oncology patients
|
Turner, Kati
|
|
|
48 |
S1 |
p. S37
|
artikel
|
| 72 |
38 Use of postoperative opioids in patients undergoing robotic hysterectomy for endometrial cancer with or without abdominal wall block
|
Bondre, Ioana L.
|
|
|
48 |
S1 |
p. S21
|
artikel
|
| 73 |
9 Utilization of care and alignment of screening with National Comprehensive Cancer Network Guidelines for patients with Lynch syndrome
|
Lowry, Christina M.
|
|
|
48 |
S1 |
p. S5-S6
|
artikel
|
| 74 |
10 Validation of a hereditary cancer risk assessment scoring tool for use by non-genetics trained healthcare workers
|
Zielenbach, Molly
|
|
|
48 |
S1 |
p. S6
|
artikel
|
Tijdschrift beschrijving